Research Reports | Market Assessment
July 2014

Type 2 Diabetes | Pharmacor | Brazil | 2014

In 2013, Brazil’s total pharmaceutical market for type 2 diabetes rivaled the size of some of the major markets. Increasing public awareness, an aging population, and the launch of new premium-priced antidiabetic agents will all contribute to the growth of this market in the next five years. The large, growing prevalent population promises a 7% annual growth in sales and significant opportunity for multinational pharmaceutical companies as demand for branded antidiabetic drugs continues to grow throughout Brazil.

Login to access report
Back to all Market Assessment reports
Login to access report

launch Related Market Assessment Reports